This page is an unofficial mirror and is not legal advice. Verify the document against the official source before relying on it.

HB1796-FN: allowing the use of psilocybin in approved clinical settings to treat qualified medical conditions.

s findings and recommendations, within 180 days of the effective date of this chapter. 4 New Subparagraph; Application of Receipts; Therapeutic Psilocybin Treatment Fund. Amend RSA 6:12, I(b) by inserting after subparagraph (410) the following new subparagraph: (411) Moneys deposited in the therapeutic psilocybin treatment fund as established in RSA 126-XX:11. 5 Effective Date. This act shall ta

Related law links

RSA references in this bill

  • 126-X · reference
  • 318-B · reference
  • 326-B · reference
  • 328-D · reference
  • 329 · reference
  • 329-B · reference
  • 330-A · reference
  • 541-A · reference
  • 6:12 · amend

RSAs mentioned by this document